Ensuring Access to Lower-Cost Medicines for Seniors Act

Summary

The bill changes the Social Security Act so that Medicare prescription drug plans and Medicare Advantage plans that use a formulary must also list any generic or biosimilar version of a drug that costs less than the brand‑name reference product. It bars plans from using stricter prior‑authorization or step‑therapy rules on those lower‑priced options and sets minimum cost‑sharing discounts for them. The aim is to lower seniors' out‑of‑pocket drug costs.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share